Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Stockholders' Equity Attributable to Parent in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q4 2020 to Q4 2023.
  • Cordyceps Sunshine Biotech Holdings Co., Ltd. Stockholders' Equity Attributable to Parent for the quarter ending December 31, 2023 was -$78.7K, a 91.7% increase year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 -$78.7K +$873K +91.7% Dec 31, 2023 20-F 2024-07-05
Q3 2023 -$183K -$300K -256% Sep 30, 2023 6-K 2023-11-13
Q4 2022 -$951K -$676K -245% Dec 31, 2022 20-F 2024-07-05
Q3 2022 $117K Sep 30, 2022 6-K 2023-11-13
Q4 2021 -$276K -$263K -2053% Dec 31, 2021 20-F 2024-07-05
Q4 2020 -$12.8K Dec 31, 2020 20-F 2024-07-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.